Detalles de la búsqueda
1.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Cancer
; 129(17): 2727-2740, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37204189
2.
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.
Transfus Med Hemother
; 50(6): 475-490, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089497
3.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Transfus Med Hemother
; 50(5): 403-416, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37899991
4.
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.
Br J Haematol
; 197(4): 431-441, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35255152
5.
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
Ann Hematol
; 101(4): 781-788, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35150296
6.
Controlled non-randomised before-after study evaluating the impact of a focused recommendation card on vaccination rates of oncological patients-The Easy Vaccination in Oncology (EVO) strategy.
Eur J Cancer Care (Engl)
; 31(6): e13725, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36221170
7.
Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry.
Ann Hematol
; 99(5): 1073-1079, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125469
8.
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis.
Ann Hematol
; 99(12): 2821-2829, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32734548
9.
Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry.
Br J Haematol
; 184(6): 949-956, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515751
10.
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia.
Haematologica
; 107(12): 2977-2982, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36005556
11.
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Leukemia
; 38(6): 1307-1314, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678093
12.
Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Int J Cancer
; 133(8): 1813-24, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23580240
13.
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.
Blood Adv
; 7(22): 7045-7055, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738090
14.
Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study.
Oncol Res Treat
; 45(4): 178-185, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34963120
15.
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
Clin Cancer Res
; 28(1): 106-115, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34615719
16.
Primary tumor excision in stage IV breast cancer at diagnosis without influence on survival: a retrospective analysis and review of the literature.
Onkologie
; 34(11): 607-12, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22104157
17.
Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53.
Cell Death Dis
; 9(3): 384, 2018 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29515122
18.
Raising Immunization Rates Among Cancer Patients.
Dtsch Arztebl Int
; 119(26): 466-467, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36321685
19.
Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma.
J Cancer Res Clin Oncol
; 141(9): 1689-95, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25804839
20.
(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
J Clin Oncol
; 31(3): 308-13, 2013 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23233718